P1017: HARBOR: A PHASE 2/3 STUDY OF BLU-263 IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS AND MONOCLONAL MAST CELL ACTIVATION SYNDROME
Authors:
Open Access
- 23 June 2022
- journal article
- abstracts
- Published by Wiley in HemaSphere
- Vol. 6 (Suppl) , 907-908